Earlier Assessment of Uncontrolled Moderate-to-Severe Asthma. Is There More We Can Do?

May 20 @ 11:55 am 12:15 pm PDT

Innovation Hub 2
Supported By Sanofi and Regeneron

Stop by during lunch and listen to an expert present a case-based review of uncontrolled asthma currently managed with medium-dose inhaled corticosteroids. This will be an open-air presentation on the clinical importance of identifying type 2 inflammation in patients with uncontrolled asthma earlier in the course of disease.

Presenter: Maureen George PhD, RN, AE-C, FAAN
Columbia University School of Nursing
Professor of Nursing
New York, New York